Show simple item record

dc.contributor.authorDoshi, Peter
dc.date.accessioned2017-05-25T01:11:39Z
dc.date.available2017-05-25T01:11:39Z
dc.date.issued2015-06-12
dc.identifier.citationDoshi, P. (2015). FDA drug summaries: a simplification too far? BMJ 2015;350:h3135. DOI: https://doi.org/10.1136/bmj.h3135en_US
dc.identifier.urihttp://hdl.handle.net/10713/6595
dc.descriptionThe FDA has launched a new tool to help patients understand a drug’s risks and benefits. However, Peter Doshi speculates that in an effort to keep the content simple important information is being left outen_US
dc.description.urihttp://bmj.com/cgi/content/full/bmj.h3135?ijkey=5LaMEFloIg3oSld&keytype=ref
dc.language.isoen_USen_US
dc.publisherBMJ Publishing Groupen_US
dc.subjectFDA drug trial snapshotsen_US
dc.subjectresearch transparencyen_US
dc.subject.lcshUnited States. Food and Drug Administrationen_US
dc.subject.meshConsumer Health Informationen_US
dc.subject.meshClinical Trials as Topicen_US
dc.titleFDA drug summaries: a simplification too far?en_US
dc.typeArticleen_US
dc.identifier.doi10.1136/bmj.h3135
dc.identifier.pmid26070648
dc.description.urinameClick here for the free full-text article on publisher's websiteen_US
refterms.dateFOA2019-02-19T18:15:24Z


Files in this item

Thumbnail
Name:
Doshi_FDADrugSummaries_2015.pdf
Size:
1.292Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record